Skip to main content
Anne Moscona, MD, Pediatric Infectious Disease, New York, NY

AnneMosconaMD

Pediatric Infectious Disease • New York, NY

Professor of Pediatrics; of Microbiology/Immunology; of Physiology/Biophysics

Join to view full profile

Dr. Moscona is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Moscona's full profile

Already have an account?

  • Office

    701 West 168th St
    Hammer Health Sciences 13-06
    New York, NY 10032

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Infectious Disease, 1985 - 1988
  • Icahn School of Medicine at Mount Sinai/Kravis Children's
    Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 1982 - 1985
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1982
  • Harvard College
    Harvard CollegeBA, Biochemistry & Molecular Biology, 1974 - 1978

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1985 - 2027
  • Pediatrics
    American Board of Pediatrics Pediatrics

Publications & Presentations

PubMed

Press Mentions

  • CUIMC Update - March 15, 2021
    CUIMC Update - March 15, 2021March 15th, 2021
  • The in Vitro Multilineage Differentiation and Maturation of Lung and Airway Cells from Human Pluripotent Stem Cell–Derived Lung Progenitors in 3D
    The in Vitro Multilineage Differentiation and Maturation of Lung and Airway Cells from Human Pluripotent Stem Cell–Derived Lung Progenitors in 3DMarch 1st, 2021
  • Preparing for a New Normal, Researchers Study Molecular Basis for COVID Drug Similar to Tamiflu
    Preparing for a New Normal, Researchers Study Molecular Basis for COVID Drug Similar to TamifluDecember 4th, 2020
  • Join now to see all

Grant Support

  • Vaccines and Therapeutic Antibodies to Respiro, Rubula, Peribunya and Phenuiviridae (R2P2)-ReVAMPPWASHINGTON UNIVERSITY2024–2027
  • Broad spectrum inhibitors of paramyxovirus envelope proteinsCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2027
  • Broad spectrum inhibitors of paramyxovirus envelope proteinsCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2027
  • Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2COLUMBIA UNIVERSITY HEALTH SCIENCES2021–2026

Dr. Anne Moscona, Dr. Anne Moscona, MD, Dr. A Moscona